Breaking News newswire

Tuesday, April 24, 2012


New York, NY - April 24, 2012 -, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday, April 23rd. The Nasdaq Composite lost 30.00 (-1.00%) to close at 2,970.45.
Ardea Biosciences, Inc. (NASDAQ:RDEA) shares climbed $10.78 (51.73%) to close at $31.62 after AstraZeneca PLC agreed to buy the company for approximately $1.26 billion or $32 per share, representing a 54% premium on the closing price on April 20, 2012.
SGOCO Group Ltd. (NASDAQ:SGOC) continued to move higher and added 0.56 (23.63%) to $2.93 without any major news. The stock has been showing solid uptrend since early April and has gained over 270% since then. SGOCO Group, Ltd, formerly SGOCO Technology, Ltd., is a branded liquid crystal display solution distributor and designer in the People’s Republic of China.
Central European Distribution Corp (NASDAQ:CEDC) shares moved up 0.60 (14.12%) to close at $4.85 on the news that Central European Distribution Corp has reached an agreement to form an alliance with major shareholder Russian Standard Corp that, which would help the company to meet its near-term financial obligations.
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) shares rose 3.14 (13.70%) to close at $26.06 on reports from Bloomberg that the company has been looking for a buyer after rejecting an unsolicited bid from Bristol-Myers Squibb Co.
Get Free investor news and stock alerts at
Sign Up:
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks Join:
About is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech,   China  stocks and agriculture.
Follow on Twitter!/Investorideas
Follow on Facebook
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
From time to time buys shares in companies it features. As a policy, does not short stocks
Source -
Post a Comment